Leukemia Research
Volume 27, Issue 7 , Pages 649-654, July 2003

Analysis of the immunophenotypes of de novo acute lymphoblastic leukaemia (ALL) in the Sultanate of Oman

Department of Haematology, College of Medicine, Sultan Qaboos University & Sultan Qaboos University Hospital, Muscat, Oman

Received 6 March 2002; accepted 28 September 2002.

Abstract 

Acute lymphoblastic leukaemia (ALL) immmunophenotypes were analysed by flow cytometry in 65 Omani patients (46 children, 19 adults). Common (“CALLA-positive”) ALL was the most frequently encountered (70%) B-cell lineage immunophenotype. Among T-cell lineage ALL patients, mature T-cell ALL was the least frequent (7%). Expression of certain surface markers including CD20 and CD6 appears to have an effect on some clinical and haematological features but FAB morphology was not useful in predicting cell lineage immunophenotypes. Other interesting findings, currently of uncertain significance, include the sizeable proportions of pre-B-ALL (group V) and cortical thymocytic ALL (stage III). Results of this study should help strengthen the emerging leukaemia database of the recently established Oman National Cancer Register and thereby contribute to a successful global attack against the haematological malignancies.

Abbreviations:  Hb, Haemoglobin, Wbc, White blood cell, MoAb, Monoclonal antibody, FAB, French American British

Keywords:  Leukaemia, Lymphoblastic, Immunophenotypes, Oman

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(02)00229-1

doi:10.1016/S0145-2126(02)00229-1

Leukemia Research
Volume 27, Issue 7 , Pages 649-654, July 2003